Stock Earnings

Question 1

Quels sont les états financiers clés de Collegium Pharmaceutical Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Collegium Pharmaceutical Inc a un total d'actifs de $1,663, un bénéfice net profit de $69

Question 2

Quels sont les ratios financiers clés pour COLL ?

Accepted Answer

Le ratio de liquidité de Collegium Pharmaceutical Inc est 1.15, la marge nette est 10.93, les ventes par action sont de $15.6.

Question 3

Comment les revenus de Collegium Pharmaceutical Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Collegium Pharmaceutical Inc largest revenue segment is Pharmaceutical, at a revenue of 631,449,000 in the most earnings release.For geography, United States is the primary market for Collegium Pharmaceutical Inc, at a revenue of 631,449,000.

Question 4

Collegium Pharmaceutical Inc est-elle rentable ?

Accepted Answer

yes, selon les derniers états financiers, Collegium Pharmaceutical Inc a un bénéfice net profit de $69

Question 5

Collegium Pharmaceutical Inc a-t-elle des passifs ?

Accepted Answer

yes, Collegium Pharmaceutical Inc a un passif de 1,434

Question 6

Combien d'actions en circulation Collegium Pharmaceutical Inc a-t-elle ?

Accepted Answer

Collegium Pharmaceutical Inc a un total d'actions en circulation de 31.44

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	707	631	566	463	276	310
Revenue Growth (YoY)	23%	11%	22%	68%	-11%	5%
Cost of Revenue	306	254	240	249	126	130
Gross Profit	400	377	326	214	150	179
Selling, General & Admin	275	210	150	140	116	113
Research & Development	--	0	0	4	9	9
Operating Expenses	275	207	150	144	125	123
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	52	98	75	-28	-3	27
Income Tax Expense	16	29	27	-3	-74	0
Net Income	36	69	48	-25	71	26
Net Income Growth	-64%	44%	-292%	-135%	173%	-218%
Shares Outstanding (Diluted)	39.07	40.42	41.78	33.8	41	35.2
Shares Change (YoY)	-3%	-3%	24%	-18%	16%	5%
EPS (Diluted)	0.92	1.71	1.15	-0.74	1.74	0.76
EPS Growth	-63%	49%	-254.99%	-143%	129%	-212%
Free Cash Flow	201	203	274	-449	101	-279
Free Cash Flow Per Share	5.14	5.02	6.55	-13.28	2.46	-7.92
Gross Margin	56.57%	59.74%	57.59%	46.22%	54.34%	57.74%
Operating Margin	17.68%	26.78%	30.91%	14.9%	9.05%	18.06%
Profit Margin	5.09%	10.93%	8.48%	-5.39%	25.72%	8.38%
Free Cash Flow Margin	28.42%	32.17%	48.4%	-96.97%	36.59%	-90%
EBITDA	336	338	324	203	93	117
EBITDA Margin	47.52%	53.56%	57.24%	43.84%	33.69%	37.74%
D&A For EBITDA	211	169	149	134	68	61
EBIT	125	169	175	69	25	56
EBIT Margin	17.68%	26.78%	30.91%	14.9%	9.05%	18.06%
Effective Tax Rate	30.76%	29.59%	36%	10.71%	2,466.66%	0%

Collegium Pharmaceutical Inc (COLL) Price

COLL Stock Price Chart

COLL Income

Follow-Up Questions